A pilot clinical study of low-intensity transcranial focused ultrasound in Alzheimer’s disease

Hyeonseok Jeong; Jooyeon Jamie Im; Jong-Sik Park; Seung-Hee Na; Wonhye Lee; Seung-Schik Yoo; In-Uk Song; Yong-An Chung

doi:10.14366/usg.20138

Ultrasonography (Oct 2021)

A pilot clinical study of low-intensity transcranial focused ultrasound in Alzheimer’s disease

Hyeonseok Jeong,
Jooyeon Jamie Im,
Jong-Sik Park,
Seung-Hee Na,
Wonhye Lee,
Seung-Schik Yoo,
In-Uk Song,
Yong-An Chung

Affiliations

Hyeonseok Jeong: Department of Nuclear Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Jooyeon Jamie Im: Department of Nuclear Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Jong-Sik Park: Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Seung-Hee Na: Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Wonhye Lee: Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Seung-Schik Yoo: Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
In-Uk Song: Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Yong-An Chung: Department of Nuclear Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

DOI: https://doi.org/10.14366/usg.20138
Journal volume & issue: Vol. 40, no. 4
pp. 512 – 519

Abstract

Read online

Purpose Increasing attention has been paid to low-intensity transcranial focused ultrasound (tFUS) for its potential therapeutic effects in Alzheimer's disease (AD). While preclinical studies have shown promising therapeutic effects of low-intensity tFUS in AD models, its efficacy and safety remain unclear in humans. In this pilot study, we investigated the effects of low-intensity tFUS on blood-brain barrier opening, the regional cerebral metabolic rate of glucose (rCMRglu), and cognition in patients with AD. Methods After receiving institutional review board approval, four patients with AD received tFUS to the hippocampus immediately after an intravenous injection of a microbubble ultrasound contrast agent. Sonication was delivered at low-intensity, at a pressure level below the threshold for blood-brain barrier opening. Patients underwent brain magnetic resonance imaging, 18F-fluoro-2-deoxyglucose positron emission tomography, and neuropsychological assessments before and after the tFUS procedure. A whole-brain voxel-wise paired t test was conducted to compare rCMRglu before and after tFUS. Results The sonication, as anticipated, did not show evidence of active blood-brain barrier opening on T1 dynamic contrast-enhanced magnetic resonance imaging. rCMRglu in the superior frontal gyrus (P<0.001), middle cingulate gyrus (P<0.001), and fusiform gyrus increased after tFUS (P=0.001). Patients demonstrated mild improvement in measures of memory, executive, and global cognitive function following tFUS. No adverse events were reported. Conclusion These results suggest that hippocampal sonication with low-intensity tFUS may have beneficial effects on cerebral glucose metabolism and cognitive function in patients with AD. Further larger studies are needed to confirm the therapeutic efficacy of tFUS in AD.

Published in Ultrasonography

ISSN: 2288-5919 (Print); 2288-5943 (Online)
Publisher: Korean Society of Ultrasound in Medicine
Country of publisher: Korea, Republic of
LCC subjects: Medicine: Medicine (General): Medical technology
Website: http://e-ultrasonography.org

About the journal

Abstract

Keywords